[Congressional Bills 113th Congress]
[From the U.S. Government Publishing Office]
[H.R. 5226 Introduced in House (IH)]

113th CONGRESS
  2d Session
                                H. R. 5226

To amend the Controlled Substances Act to exclude therapeutic hemp and 
 cannabidiol from the definition of marihuana, and for other purposes.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                             July 28, 2014

 Mr. Perry (for himself, Mr. Rohrabacher, Mr. Cohen, and Mr. Broun of 
   Georgia) introduced the following bill; which was referred to the 
 Committee on Energy and Commerce, and in addition to the Committee on 
   the Judiciary, for a period to be subsequently determined by the 
  Speaker, in each case for consideration of such provisions as fall 
           within the jurisdiction of the committee concerned

_______________________________________________________________________

                                 A BILL


 
To amend the Controlled Substances Act to exclude therapeutic hemp and 
 cannabidiol from the definition of marihuana, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Charlotte's Web Medical Hemp Act of 
2014''.

SEC. 2. EXCLUSION OF THERAPEUTIC HEMP AND CANNABIDIOL FROM DEFINITION 
              OF MARIHUANA.

    (a) In General.--Section 102 of the Controlled Substances Act (21 
U.S.C. 802) is amended in paragraph (16)--
            (1) by striking ``(16) The'' and inserting ``(16)(A) The''; 
        and
            (2) by adding at the end the following:
            ``(B) Therapeutic hemp and cannabidiol--
            ``(i) are excluded from the definition of marihuana under 
        subparagraph (A); and
            ``(ii) shall not be treated as controlled substances under 
        this Act.''.
    (b) Definition.--Section 102 of the Controlled Substances Act (21 
U.S.C. 802), as amended, is further amended by adding at the end the 
following:
    ``(57) The term `therapeutic hemp' means the plant Cannabis sativa 
L. and any part of such plant, whether growing or not, with a delta-9 
tetrahydrocannabinol concentration of not more than 0.3 percent on a 
dry weight basis.
    ``(58) The term `cannabidiol' means the substance cannabidiol, as 
derived from therapeutic hemp.''.

SEC. 3. OTHER LIMITATIONS.

    (a) Non-Applicability of Federal Food, Drug, and Cosmetic Act.--The 
Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301 et seq.) shall not 
apply to therapeutic hemp or cannabidiol as those terms are defined in 
section 102 of the Controlled Substances Act (21 U.S.C. 802) as amended 
by this Act.
    (b) State Law.--Nothing in this Act shall prohibit or otherwise 
restrict any activities related to the use, production, or distribution 
of marijuana in a State in which such activities are legal under State 
law.
                                 <all>